Company Data
Inhibikase Therapeutics Inc.
Ticker
IKT
Current Price
$0.64 1.59%
Market Cap
$18.5M
Price Target
Refer to Report
Volume
28.5K
52wk Range
$0.4401 - $1.2097
Overview
Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson’s disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.
Other Considerations
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
